HC Wainwright & Co. Reiterates Buy on ChromaDex, Maintains $6 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on ChromaDex (NASDAQ:CDXC) and maintained a price target of $6.
July 15, 2024 | 10:40 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on ChromaDex and maintained a price target of $6, indicating continued confidence in the company's prospects.
The reiteration of a Buy rating and maintenance of a $6 price target by HC Wainwright & Co. suggests strong confidence in ChromaDex's future performance. This positive analyst rating is likely to boost investor sentiment and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100